New

Onychomycosis Treatment Market

2021

Onychomycosis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment Type ( Oral and Topical ); Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Others )

| Report Code: TIPRE00019314 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Onychomycosis Treatment Market 2028 By Treatment Type, Distribution Channel | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Nail fungus is also called onychomycosis. It is among the common conditions that begin as a white either yellow spot under the tip of the fingernail or toenail. Eventually, when the fungal infection goes more extensive, the nail fungus can cause discoloring of the nail, thicken and crumble at the edge. It can affect several nails. In the case of nail fungus causes pain and cause thickened nails, the possible treatment is self-care steps and medications. However, nail fungus often comes back even if treatment is successful.

MARKET DYNAMICS

The Onychomycosis Treatment market is driving due to the increasing awareness regarding dermatophytic onychomycosis among podiatrists and dermatologists, rising prevalence of onychomycosis. However, lack of awareness among the people is expected to hamper the growth of the global onychomycosis treatment market.

MARKET SCOPE

The "Onychomycosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of onychomycosis treatment market with detailed market segmentation by treatment type and distribution channel. The onychomycosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in onychomycosis treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The onychomycosis treatment market is segmented on the basis of treatment type and distribution channel. Based on treatment type, the market is segmented as oral and topical. On distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, drug stores, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the onychomycosis treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The onychomycosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting onychomycosis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the onychomycosis treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the onychomycosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from onychomycosis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for onychomycosis treatment in the global market. Below mentioned is the list of few companies engaged in the onychomycosis treatment market.

The report also includes the profiles of key players in onychomycosis treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Valeant Pharmaceuticals Inc.
  •  Galderma S.A.
  •  Novartis AG
  •  Pfizer, Inc.
  •  Moberg Pharma AB
  •  Johnson and Johnson Services, Inc.
  •  Bayer AG
  •  Dr. Reddy’s Laboratories Ltd.
  •  Cipla Ltd.
  •  Medimetriks Pharmaceuticals, Inc.

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Onychomycosis Treatment Market - By Treatment Type
1.3.2 Onychomycosis Treatment Market - By Distribution Channel
1.3.3 Onychomycosis Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONYCHOMYCOSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ONYCHOMYCOSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONYCHOMYCOSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. ONYCHOMYCOSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ONYCHOMYCOSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ONYCHOMYCOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
7.1. OVERVIEW
7.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. TOPICAL
7.4.1. Overview
7.4.2. Topical Market Forecast and Analysis
8. ONYCHOMYCOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ONYCHOMYCOSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Onychomycosis Treatment Market Overview
9.1.2 North America Onychomycosis Treatment Market Forecasts and Analysis
9.1.3 North America Onychomycosis Treatment Market Forecasts and Analysis - By Treatment Type
9.1.4 North America Onychomycosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Onychomycosis Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Onychomycosis Treatment Market
9.1.5.1.1 United States Onychomycosis Treatment Market by Treatment Type
9.1.5.1.2 United States Onychomycosis Treatment Market by Distribution Channel
9.1.5.2 Canada Onychomycosis Treatment Market
9.1.5.2.1 Canada Onychomycosis Treatment Market by Treatment Type
9.1.5.2.2 Canada Onychomycosis Treatment Market by Distribution Channel
9.1.5.3 Mexico Onychomycosis Treatment Market
9.1.5.3.1 Mexico Onychomycosis Treatment Market by Treatment Type
9.1.5.3.2 Mexico Onychomycosis Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Onychomycosis Treatment Market Overview
9.2.2 Europe Onychomycosis Treatment Market Forecasts and Analysis
9.2.3 Europe Onychomycosis Treatment Market Forecasts and Analysis - By Treatment Type
9.2.4 Europe Onychomycosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Onychomycosis Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Onychomycosis Treatment Market
9.2.5.1.1 Germany Onychomycosis Treatment Market by Treatment Type
9.2.5.1.2 Germany Onychomycosis Treatment Market by Distribution Channel
9.2.5.2 France Onychomycosis Treatment Market
9.2.5.2.1 France Onychomycosis Treatment Market by Treatment Type
9.2.5.2.2 France Onychomycosis Treatment Market by Distribution Channel
9.2.5.3 Italy Onychomycosis Treatment Market
9.2.5.3.1 Italy Onychomycosis Treatment Market by Treatment Type
9.2.5.3.2 Italy Onychomycosis Treatment Market by Distribution Channel
9.2.5.4 Spain Onychomycosis Treatment Market
9.2.5.4.1 Spain Onychomycosis Treatment Market by Treatment Type
9.2.5.4.2 Spain Onychomycosis Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Onychomycosis Treatment Market
9.2.5.5.1 United Kingdom Onychomycosis Treatment Market by Treatment Type
9.2.5.5.2 United Kingdom Onychomycosis Treatment Market by Distribution Channel
9.2.5.6 Rest of Europe Onychomycosis Treatment Market
9.2.5.6.1 Rest of Europe Onychomycosis Treatment Market by Treatment Type
9.2.5.6.2 Rest of Europe Onychomycosis Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Onychomycosis Treatment Market Overview
9.3.2 Asia-Pacific Onychomycosis Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Onychomycosis Treatment Market Forecasts and Analysis - By Treatment Type
9.3.4 Asia-Pacific Onychomycosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Onychomycosis Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Onychomycosis Treatment Market
9.3.5.1.1 Australia Onychomycosis Treatment Market by Treatment Type
9.3.5.1.2 Australia Onychomycosis Treatment Market by Distribution Channel
9.3.5.2 China Onychomycosis Treatment Market
9.3.5.2.1 China Onychomycosis Treatment Market by Treatment Type
9.3.5.2.2 China Onychomycosis Treatment Market by Distribution Channel
9.3.5.3 India Onychomycosis Treatment Market
9.3.5.3.1 India Onychomycosis Treatment Market by Treatment Type
9.3.5.3.2 India Onychomycosis Treatment Market by Distribution Channel
9.3.5.4 Japan Onychomycosis Treatment Market
9.3.5.4.1 Japan Onychomycosis Treatment Market by Treatment Type
9.3.5.4.2 Japan Onychomycosis Treatment Market by Distribution Channel
9.3.5.5 South Korea Onychomycosis Treatment Market
9.3.5.5.1 South Korea Onychomycosis Treatment Market by Treatment Type
9.3.5.5.2 South Korea Onychomycosis Treatment Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Onychomycosis Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Onychomycosis Treatment Market by Treatment Type
9.3.5.6.2 Rest of Asia-Pacific Onychomycosis Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Onychomycosis Treatment Market Overview
9.4.2 Middle East and Africa Onychomycosis Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Onychomycosis Treatment Market Forecasts and Analysis - By Treatment Type
9.4.4 Middle East and Africa Onychomycosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Onychomycosis Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Onychomycosis Treatment Market
9.4.5.1.1 South Africa Onychomycosis Treatment Market by Treatment Type
9.4.5.1.2 South Africa Onychomycosis Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Onychomycosis Treatment Market
9.4.5.2.1 Saudi Arabia Onychomycosis Treatment Market by Treatment Type
9.4.5.2.2 Saudi Arabia Onychomycosis Treatment Market by Distribution Channel
9.4.5.3 U.A.E Onychomycosis Treatment Market
9.4.5.3.1 U.A.E Onychomycosis Treatment Market by Treatment Type
9.4.5.3.2 U.A.E Onychomycosis Treatment Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Onychomycosis Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Onychomycosis Treatment Market by Treatment Type
9.4.5.4.2 Rest of Middle East and Africa Onychomycosis Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Onychomycosis Treatment Market Overview
9.5.2 South and Central America Onychomycosis Treatment Market Forecasts and Analysis
9.5.3 South and Central America Onychomycosis Treatment Market Forecasts and Analysis - By Treatment Type
9.5.4 South and Central America Onychomycosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Onychomycosis Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Onychomycosis Treatment Market
9.5.5.1.1 Brazil Onychomycosis Treatment Market by Treatment Type
9.5.5.1.2 Brazil Onychomycosis Treatment Market by Distribution Channel
9.5.5.2 Argentina Onychomycosis Treatment Market
9.5.5.2.1 Argentina Onychomycosis Treatment Market by Treatment Type
9.5.5.2.2 Argentina Onychomycosis Treatment Market by Distribution Channel
9.5.5.3 Rest of South and Central America Onychomycosis Treatment Market
9.5.5.3.1 Rest of South and Central America Onychomycosis Treatment Market by Treatment Type
9.5.5.3.2 Rest of South and Central America Onychomycosis Treatment Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ONYCHOMYCOSIS TREATMENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ONYCHOMYCOSIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. VALEANT PHARMACEUTICALS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GALDERMA S.A.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MOBERG PHARMA AB
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BAYER AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DR. REDDY’S LABORATORIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CIPLA LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MEDIMETRIKS PHARMACEUTICALS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Valeant Pharmaceuticals Inc.
2. Galderma S.A.
3. Novartis AG
4. Pfizer, Inc.
5. Moberg Pharma AB
6. Johnson and Johnson Services, Inc.
7. Bayer AG
8. Dr. Reddy's Laboratories Ltd.
9. Cipla Ltd.
10. Medimetriks Pharmaceuticals, Inc.
TIPRE00019314
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.